Avalon Ventures

Avalon Ventures, LLC is a venture capital firm specializing in seed, early stage, mid venture, late venture, and growth capital investments. The firm seeks to invest in information technology, media technology, software, wireless, life science industries, biotechnology, pharmaceuticals, internet, web broadcasts and cybercasts. It prefers to invest in companies based in the United States with a focus on the Northeast region, California and San Diego region. Avalon Ventures, LLC was founded in 1983 and is headquartered in La Jolla, California with an additional office in Cambridge, Massachusetts.

Brady Bohrmann

MD

Kevin Kinsella

MD

RL

Rich Levandov

MD

Jay B. Lichter

MD

Steve Tomlin

MD

172 past transactions

Silarus Therapeutics

Series A in 2014
Silarus Therapeutics is developing therapeutics targeting erythroferrone for the treatment of iron deficiency and iron overload disorders. Erythroferrone is a recently-discovered hormone that regulates the iron supply for red blood cell production. Iron deficiency, also known as anemia, is a condition in which blood does not contain the normal amount of red blood cells or lacks the proper amount of hemoglobin. This, in turn, lowers the amount of oxygen-rich blood in circulation, causing shortness of breath, dizziness or headaches.

Avelas Biosciences

Series C in 2016
Avelas BioSciences, Inc. is a clinical stage biotechnology company that focuses on developing technologies that advance care for cancer surgery and therapeutic intervention. It develops AVB-620, an intravenously administered in vivo fluorescent protease-activatable peptide that detects, marks, and diagnoses cancer. The company was incorporated in 2008 and is based in La Jolla, California.

Overlap.cc

Seed Round in 2016
Overlapan develops an online intelligent personal assistant for scheduling meetings via email. It allows users to email their guests a meeting request and carbon copy their private assistants; interprets their email and identifies available time slots in users’ calendar and sends back an email with clickable options; and allows users to approve the guest's proposed time, as well as to invite and book meetings. The company is based in New York, New York.

AnaptysBio, Inc.

Series A in 2006
AnaptysBio is a privately-held therapeutic antibody product company that uses of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease. The Company's SHM-Platform utilizes the key components of SHM and other techniques to generate antibodies for therapeutic applications through an iterative process of natural evolution and high-throughput selection a process that has been referred to as naturalizing antibodies. This versatile platform can be used both to discover and optimize antibodies directed at specific disease targets and also affinity mature existing antibodies to improve their binding properties. In addition to providing a more powerful approach to antibody discovery and protein optimization, it addresses a growing void in the therapeutic antibody field due to a string of acquisitions and licensing deals that have reduced the availability of many technologies.

Skycatch, Inc.

Series B in 2015
Skycatch builds technology to autonomously capture, process, and analyze 3D drone data to provide companies with an accurate visualization of the physical world. It is the leading industrial data collection and analytics company, focused on indexing and extracting critical information from the physical world. They use a combination of hardware, software, and artificial intelligence to deliver high precision data at unprecedented speed and ease of use. It was incorporated in 2013 and is based in San Francisco, California.

Pictela

Venture Round in 2010
Pictela is now integrated into ONE by AOL. AOL Platforms enables the world's top marketers and media brands to reach consumers across desktop, mobile and TV through premium experiences, programmatic buying and performance-driven campaigns. It is the global partner of choice for leading publishers, advertisers and agencies seeking to maximize the value of their brands online. For more information, please visit onebyaol.com.

Cheezburger

Venture Round in 2012
Cheezburger is a Seattle-based company that operates a network of social humor websites, including such as I Can Has Cheezburger, FAIL Blog, Know Your Meme, and Memebase. It enables its website visitors to view, create, or remix themes and share their favorite funny pictures. Cheezburger has published five books: A LOLcat Colleckshun, How to Take Over Teh Wurld, FAIL Nation, GRAPH OUT LOUD, and I HAS A HOTDOG: What Your Dog Is Really Thinking. Cheezburger was founded by Ben Huh and Eric Nakagawa in September 2007 and is based in Seattle, Washington.

Sidecar Technologies

Series B in 2014
Sidecar is building the world most convenient and affordable transportation network created for and powered by every day people. All drivers are pre-vetted for safety and are free to give rides whenever they want. Sidecar safety system includes driver background checks, driver and rider rating systems, GPS tracking features and the ability to share details of your trip in real-time. Sidecar was founded in San Francisco in 2011 and currently operates in ten cities and has facilitated more than half a million rides.
Cambrios Technologies Corp. develops electronic materials for the display industry. The company provides wet-processable transparent conductive films. Its nanostructured materials can be deposited using existing production equipment to achieve enhanced performance of display devices and components. The company was founded in 2002 as Semzyme, Inc. and changed its name to Cambrios Technologies Corp. in August 2004. Cambrios Technologies Corp. is based in Sunnyvale, California.

Intercasting

Series A in 2005
Intercasting is a mobile social networking company. Through its flagship ANTHEM 2.0 platform, wireless carriers and device manufacturers can add instant messaging, email, and social networking to their offerings. Founded in 2004, Intercasting was one of the first companies to deploy a carrier-grade mobile blogging and social networking application in North America with Rabble.

Shelby.tv

Seed Round in 2011
Shelby.tv is the best way to discover and enjoy web video. Now available in the App Store, the Shelby.tv app delivers you a personalized channel of videos from sources like YouTube, Vimeo, Hulu, Blip, and DailyMotion, as well as video shared by your friends on Twitter, Tumblr, and Facebook. Over time, Shelby.tv gets smart about what you like and don’t like and improves recommendations to give you that perfect daily dose of video entertainment.

Redbooth

Series B in 2014
Redbooth is a task and project management platform that provides a single place for team collaboration such as tasks, discussions, and file sharing. Redbooth is simple and flexible to use, enabling project teams and departments at thousands of companies to get work done. Redbooth is used by over 400,000 organizations, including AT&T, Avis, BBC, Canal+, Cisco, Deutsche Telekom, Duke University, Harvard University, Intuit, Novartis, Subaru, ReMax, and Volkswagen Audi. Founded in 2008, the company is privately held and headquartered in Palo Alto, California.

Ortiva Wireless

Series B in 2007
Ortiva Wireless, Inc. offers solutions for the management of mobile video. It offers mobile video optimization gateway, a server-based optimization solution, which provides asset preparation, transcoding, and streaming for live and video on demand content. The company’s product also optimizes multimedia content for delivery to mobile subscribers. It serves mobile network operators and managed service providers. Ortiva Wireless, Inc. was founded in 2004 and is based in La Jolla, California.

Figg

Funding Round in 2020
Figg is a card-linked marketing company. Our unique advertising platform enables brands of every size to market to consumers in a private marketplace of banks and publishers. Bank and publisher partners leverage our platform to provide advertiser-funded offers to their customers, driving sustainable loyalty. Today, Figg is the only card-linked platform company supporting both card-specific bank programs and a platform where consumers can enroll any card they choose. Powerful transaction data enables advertisers to reach specific consumer segments with unparalleled targeting and precise attribution of marketing spend.

Jnana

Series B in 2021
Jnana Therapeutics Inc. operates a drug discovery platform focused on solute carrier (SLC). The company is focusing on immunometabolism, lysosomal function, and mucosal defense, important disease pathways where SLC transporters provides target for immuno-oncology, inflammatory disorders, and neurological diseases. The company was founded in 2016 and is based in Boston, Massachusetts.

Primer

Series C in 2021
Primer Technologies, Inc. develops software that uses machine learning techniques to help parse and collate a large number of documents across several languages. The company's systems read documents, discover insights, and automatically generate reports comparable to those of a human analyst. It helps governments and corporations monitor and understand the world’s information. Primer Technologies, Inc. was incorporated in 2014 and is based in San Francisco, California.

Shelby.tv

Series A in 2012
Shelby.tv is the best way to discover and enjoy web video. Now available in the App Store, the Shelby.tv app delivers you a personalized channel of videos from sources like YouTube, Vimeo, Hulu, Blip, and DailyMotion, as well as video shared by your friends on Twitter, Tumblr, and Facebook. Over time, Shelby.tv gets smart about what you like and don’t like and improves recommendations to give you that perfect daily dose of video entertainment.

Indix Corporation

Series B in 2015
Indix has built a Products Platform that delivers product information and commerce-ready services for a fraction of the cost of alternatives. Indix combines AI with the largest collection of product data available: price, availability, and seller information, along with code-based identifiers and attributes. Businesses use the Indix Platform to improve the size and quality of their digital product catalog and develop innovative ways to buy and sell products.

Synthorx, Inc.

Series B in 2016
Synthorx, Inc., a biopharmaceutical company, focuses on the development of cytokine Synthorin programs for the treatment of cancer and autoimmune disorders in the United States. The company's lead product candidate is THOR-707, a variant of recombinant human IL-2 that is in the development in various solid tumor types as a single agent and in combination with an immune checkpoint inhibitor. It also develops IL-2 Synthorin for autoimmune indications; IL-10 Synthorin, a naturally occurring immune cell growth factor in humans for the treatment of immuno-oncology (IO); and IL-15 Synthorins, an immunoregulatory cytokine to treat IO. In addition, the company develops other Synthorin programs targeting undisclosed cytokines that play critical roles in the orchestration of anti-tumor responses by innate and adaptive immune cells. The company was formerly known as Alinos, Inc. and changed its name to Synthorx, Inc. in March 2014. Synthorx, Inc. was founded in 2014 and is headquartered in La Jolla, California. As of January 23, 2020, Synthorx, Inc. operates as a subsidiary of Sanofi.

Byliner

Series A in 2012
Byliner works directly with the world's best writers to deliver their stories to readers. Hailed by Fast Company as “One of the 10 Most Innovative Media Companies in the World,” we publish original fiction and nonfiction e-shorts by top authors such as Amy Tan, Margaret Atwood, Jon Krakauer, Nick Hornby, Sebastian Junger, and more. These e-shorts are written to be read in two hours or less, and can be purchased individually through major digital bookstores. The entire Byliner Originals library is also available online to Byliner subscribers, who get access to premium content from Byliner's by-invitation community of writers--including thousands of rarely-seen and exclusive stories from bestselling authors.

Techstars Kansas City Accelerator

Venture Round in 2011
The Techstars Dubai Accelerator in partnership with GINCO is expanding Techstars’ presence in the Middle East. GINCO is a full service general contracting firm, covering the full lifecycle of the construction process from concept to execution and supervision. Dubai is known for their leadership in technology innovation. Pioneering entrepreneurs leading innovative companies solving challenges in transportation, construction, wellness, IoT, robotics, & beyond should apply, no matter your location.

Cloudant

Series A in 2008
Cloudant’s distributed database-as-a-service (DBaaS) allows developers of fast-growing web and mobile apps to focus on building and improving their products, instead of worrying about scaling and managing their databases on their own. Cloudant was founded in Cambridge, Massachusetts in 2008 by three MIT physicists who at the time were moving multi-petabyte data sets around from the Large Hadron Collider. Frustrated by the available tools for managing and analyzing Big Data in their research, the founders built a distributed, fault-tolerant, globally scalable data layer on top of Apache CouchDB. The service has grown since then. The team now manages and serves mobile and web app data on behalf of thousands of developers and hundreds of customers to their users around the world.

Amira Pharmaceuticals

Series B in 2007
Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. Their discovery team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and fibrotic diseases.

Redbooth

Series A in 2013
Redbooth is a task and project management platform that provides a single place for team collaboration such as tasks, discussions, and file sharing. Redbooth is simple and flexible to use, enabling project teams and departments at thousands of companies to get work done. Redbooth is used by over 400,000 organizations, including AT&T, Avis, BBC, Canal+, Cisco, Deutsche Telekom, Duke University, Harvard University, Intuit, Novartis, Subaru, ReMax, and Volkswagen Audi. Founded in 2008, the company is privately held and headquartered in Palo Alto, California.

Cardeas Pharma

Series B in 2015
Cardeas Pharma is developing a novel antibiotic formulation of two drugs with synergistic activity against all relevant, highly resistant Gram-negative bacilli, including Pseudomonas aeruginosa, Acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. In addition, this antibiotic formulation has activity on biofilms. The combination also has activity against Gram-positive pathogens including methicillin-resistant Staphylococcus aureus (MRSA). This formulation is administered using a single-patient use, vibrating-plate nebulizer that is compatible with all ventilators. The nebulizer creates small, uniform aerosol droplets that deliver drug to the small airways and alveoli. Integration of this novel antibiotic formulation and device has the potential to achieve significant clinical outcomes relative to current standard therapy.

Simulmedia

Series C in 2012
Simulmedia Inc., a technology company, provides a digital advertisement targeting platform for linear television. It provides VAMOS, a data-driven predictive analytics platform for TV. The company also offers TV advertising campaigns. It serves marketers, agencies, TV media owners, and distributors. The company was founded in 2008 and is based in New York, New York with an additional location in San Francisco, California.

Backupify

Series B in 2011
Backupify is a backup technology provider for cloud-based data, offering archiving, search and restore solutions for online services.

Backupify

Series C in 2012
Backupify is a backup technology provider for cloud-based data, offering archiving, search and restore solutions for online services.

BotChain

Venture Round in 2018
BotChain enables universal registration, identity validation, audit, and coordination of A.I. agents and autonomous software. The BotChain was created by the team at Talla. After more than two years of building intelligent, AI-driven bots for the enterprise, Talla began pursuing their idea for BotChain. The leadership team represents decades of experience in software development, Artificial Intelligence, startups, and innovation.
Syndax Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors. It offers therapies to treat solid tumors and lung, breast, and hematological cancer. The company is developing axatilimab, a monoclonal antibody that blocks the colony-stimulating factor 1 (CSF-1) receptor, in development for chronic Graft versus Host Disease, and entinostat, a class I HDAC inhibitor. Syndax Pharmaceuticals pipeline includes and SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, in development for the treatment of patients with MLLr and NPM1 acute leukemias.

Empyr

Series B in 2012
Figg is a card-linked platform company uncovering value for advertisers, publishers, and consumers through trusted data insights. Figg is redefining the way advertisers and consumers connect through everyday purchases. Its card-linked platform features the most diverse portfolio of advertiser-funded offers to enrich savings for consumers. The company enables advertisers to design custom offers aimed at building long-term loyalty for leading social platforms, financial institutions, and mobile apps.

Primer

Venture Round in 2015
Primer Technologies, Inc. develops software that uses machine learning techniques to help parse and collate a large number of documents across several languages. The company's systems read documents, discover insights, and automatically generate reports comparable to those of a human analyst. It helps governments and corporations monitor and understand the world’s information. Primer Technologies, Inc. was incorporated in 2014 and is based in San Francisco, California.

Chumby

Series A in 2006
chumby streams your favorite parts of the Internet in a fun, always-on, always-fresh format.
Cambrios Technologies Corp. develops electronic materials for the display industry. The company provides wet-processable transparent conductive films. Its nanostructured materials can be deposited using existing production equipment to achieve enhanced performance of display devices and components. The company was founded in 2002 as Semzyme, Inc. and changed its name to Cambrios Technologies Corp. in August 2004. Cambrios Technologies Corp. is based in Sunnyvale, California.

Otonomy, Inc.

Series C in 2013
Otonomy was founded in 2008 by Avalon Ventures and experts in the otology field in order to build the premier company dedicated to the treatment of otic disorders via localized drug delivery. This approach has already been widely adopted for the delivery of short-acting antibiotics to treat otitis media through a tympanostomy tube. In addition, otolaryngologists have demonstrated that the injection of steroids into the middle ear cavity can provide a therapeutic effect for patients with acute inner ear disorders such as Ménière’s disease and sudden sensorineural hearing loss. Expansion of this effort holds great promise for the treatment of chronic hearing loss, severe vertigo, and even tinnitus. The key to Otonomy's leading position in this nascent field is the development of a proprietary formulation platform that provides sustained drug exposure from a single administration. Broad application of this technology has already been established across a number of therapeutic classes and from these, three product candidates have been advanced into development.

Intercasting

Series B in 2007
Intercasting is a mobile social networking company. Through its flagship ANTHEM 2.0 platform, wireless carriers and device manufacturers can add instant messaging, email, and social networking to their offerings. Founded in 2004, Intercasting was one of the first companies to deploy a carrier-grade mobile blogging and social networking application in North America with Rabble.

Vocera Communications

Venture Round in 2004
Vocera provides mobile communication solutions addressing critical communication challenges facing hospitals today. They help their customers improve patient safety and satisfaction, and increase hospital efficiency and productivity through their Voice Communication solution, Secure Messaging applications and Care Transition solutions. Exclusively endorsed by the American Hospital Association, the Vocera solutions are installed in more than 800 hospitals and healthcare facilities worldwide. The company is headquartered in San Jose, Calif., with offices in Tennessee, Canada and the United Kingdom.

Cheezburger

Venture Round in 2011
Cheezburger is a Seattle-based company that operates a network of social humor websites, including such as I Can Has Cheezburger, FAIL Blog, Know Your Meme, and Memebase. It enables its website visitors to view, create, or remix themes and share their favorite funny pictures. Cheezburger has published five books: A LOLcat Colleckshun, How to Take Over Teh Wurld, FAIL Nation, GRAPH OUT LOUD, and I HAS A HOTDOG: What Your Dog Is Really Thinking. Cheezburger was founded by Ben Huh and Eric Nakagawa in September 2007 and is based in Seattle, Washington.

Simulmedia

Series E in 2019
Simulmedia Inc., a technology company, provides a digital advertisement targeting platform for linear television. It provides VAMOS, a data-driven predictive analytics platform for TV. The company also offers TV advertising campaigns. It serves marketers, agencies, TV media owners, and distributors. The company was founded in 2008 and is based in New York, New York with an additional location in San Francisco, California.

Janux Therapeutics

Series A in 2021
Janux Therapeutics develops immunotherapies that generate immune responses to prevent tumors and not affecting a patient’s healthy tissue. Janux technology targets all three stages of the anti-tumor immune response. Janux Therapeutics, Inc. was founded in 2017 by David Campbell and is based in La Jolla, California.

Empyr

Series B in 2014
Figg is a card-linked platform company uncovering value for advertisers, publishers, and consumers through trusted data insights. Figg is redefining the way advertisers and consumers connect through everyday purchases. Its card-linked platform features the most diverse portfolio of advertiser-funded offers to enrich savings for consumers. The company enables advertisers to design custom offers aimed at building long-term loyalty for leading social platforms, financial institutions, and mobile apps.

Tapad Inc.

Series B in 2013
Tapad is a global marketing technology company providing a comprehensive suite of identity-based marketing solutions. By leveraging the company’s proprietary and privacy-safe Tapad Graph. Their groundbreaking, proprietary technology assimilates billions of data points to find the human relationship between smartphones, desktops, laptops, tablets, connected TVs, and game consoles. The result: an unprecedented understanding of consumer behavior across related screens and the ability to reach the right people on the right device at the right time. With Tapad, publishers and advertisers can deepen consumer engagement with a more fluid experience while increasing campaign cost-effectiveness. The company is reinventing personalization for the modern marketer through its identity-driven solutions. The Tapad Graph combines the company’s proprietary Device Graph with behavioral signals so marketers can finally see their customers as unique individuals, and ultimately, deliver personalization at scale.

Kalon Semiconductor

Series A in 2006
Kalon Semiconductor, a semiconductor company, develops connectivity products for wireless and wired applications. It offers ultra wideband technology for in-home multimedia, wireless USB, wireless high definition video, and Bluetooth 3.0. connectivity. The company serves manufacturers of network devices, display monitors, televisions, media adapters, set top boxes, media center computers, laptop computers, handsets, PDAs, and USB connectivity products. Kalon Semiconductor, Inc. was founded in 2005 and is based in San Diego, California with an additional office in Taipei, Taiwan.

Joy

Series A in 2018
Joy Life, Inc. develops a wedding planning portal and application tools. Its portal and applications enable users to add photos, choose wedding colors and fonts, invite guests, send and store RSVP information, send messages, control social network sharing, import spreadsheets, register gifts, send digital RSVPs, and send custom notifications and messages. The company’s portal also allows guests to take and upload photos to private moments timeline, comment, and show love for photos. Joy Life, Inc. was founded in 2014 and is based in San Francisco, California.

Otonomy, Inc.

Series A in 2010
Otonomy was founded in 2008 by Avalon Ventures and experts in the otology field in order to build the premier company dedicated to the treatment of otic disorders via localized drug delivery. This approach has already been widely adopted for the delivery of short-acting antibiotics to treat otitis media through a tympanostomy tube. In addition, otolaryngologists have demonstrated that the injection of steroids into the middle ear cavity can provide a therapeutic effect for patients with acute inner ear disorders such as Ménière’s disease and sudden sensorineural hearing loss. Expansion of this effort holds great promise for the treatment of chronic hearing loss, severe vertigo, and even tinnitus. The key to Otonomy's leading position in this nascent field is the development of a proprietary formulation platform that provides sustained drug exposure from a single administration. Broad application of this technology has already been established across a number of therapeutic classes and from these, three product candidates have been advanced into development.

Cadherx Therapeutics

Series A in 2015
Develops therapeutic antibodies targeting soluble E-cadherin.

RQx Pharmaceuticals

Series A in 2011
RQx Pharmaceuticals, Inc., a biopharmaceutical company, develops broad spectrum antibiotics. The company was founded in 2010 and is based in La Jolla, California.

Kaltura

Series C in 2011
Kaltura provides an open-source online video platform for 100,000 media entertainment companies, enterprises, SMBs, educational institutions, service providers, platform vendors, and system integrators

Inogen

Series D in 2007
Inogen is innovation in oxygen therapy. Our mission is to improve freedom and independence for oxygen therapy patients through innovative products and services. As a manufacturer and Accredited Homecare Provider dedicated to oxygen therapy, Inogen is ideally suited to develop products tailored to oxygen therapy users and to provide superior service to those users in their homes.

MOGL

Venture Round in 2014
MOGL is a restaurant rewards app on a mission to end hunger in the US. Members earn 10% cash-back at 1000's of participating restaurants by paying with a linked credit or debit card. Within seconds of paying they will get an alert on their phone giving them the option to donate some or all of the cash-back to a local food bank. Members can track the progress being made in their city using the Hunger Tracker and compete against friends to see who can donate the most meals. MOGL Loyalty Services, Inc. was founded in 2010 and is based in Solana Beach, California.

Ad Summos

Venture Round in 2010
UPDATE: ad summos is now Korrelate. ad summos helps publishers realize the full fair value of their inventory by aggregating precision audiences at scale in premium environments with Real ROI TM for advertisers. Real ROI TM closes the O2O TM (offline to online) attribution loop on a census basis for the 90% of transactions that occur offline while guaranteeing consumer privacy and anonymity. By integrating real-time media and audience intelligence directly into the publisher's ad server, we turn the centralized RTB exchange model inside-out: we empower publishers and enable online marketing campaigns that are not possible with exchange-transacted media. Ad summos has headquarters based in New York City with engineering offices in Orlando, FL. Check back for the latest updates and information on ad summos.

Thyritope Biosciences

Series A in 2014
Thyritope Biosciences is developing therapeutics that target thyroid stimulating auto-antibodies, which are the causative drivers of Graves' hyperthyroidism and Graves' orbitopathy. Graves' disease is an autoimmune disorder caused by antibodies that over-stimulate the thyroid, causing excessive thyroid hormone production. The same antibodies stimulate the tissue around the eyes, resulting in an increase of orbital fat and extra-ocular muscle volume which causes the bulging of the eyes characteristic of Graves' orbitopathy.

Smyte Inc.

Series A in 2017
Smyte Inc. provides Software-as-a-Service solution offering trust and safety as a service for websites and mobile apps. Its solutions blends manual heuristics, machine learning, and proprietary reputation data to help trust and safety and risk teams proactively stop spam, fraud, bots, phishing, harassment, and account takeover. The company serves enterprises, marketplaces, and social networks. Smyte Inc. was formerly known as Authbox, Inc. The company was founded in 2014 and is based in San Francisco, California. As of June 30, 2018, Smyte Inc. operates as a subsidiary of Twitter, Inc.

BookBub

Series A in 2014
BookBub is a rapidly growing startup launched by serial entrepreneurs and run by a team gathered from the publishing and tech industries. Every day millions of readers use our service to discover great books, and thousands of leading publishers and authors work with us to drive sales and find new fans. Connecting readers with great deals on ebooks is just the beginning for BookBub. The rise of digital publishing is altering the way books are found, purchased, and read. We’re expanding our team to help address the challenges and opportunities of the publishing industry while continuing to help readers find books and authors they’ll love.

Memrise

Seed Round in 2012
Memrise Inc. operates an online learning community that enables users to browse and learn languages, arts and literature, maths and science, natural world, history and geography, professional and careers, entertainment, and trivia courses. The company’s platform also allows teachers to create courses, as well as manage their classes. It serves users in the United States, the United Kingdom, the Netherlands, and internationally. The company was founded in 2010 and is based in London, United Kingdom.

BioVex

Series E in 2007
BioVex is a biotechnology company focused on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. Their cancer program, OncoVEXGM-CSF, is a oncolytic vaccine or cancer destroying virus technology that works by replicating and spreading within solid tumors, causing the death of cancer cells while leaving surrounding healthy cells unharmed. The attenuated virus has also been constructed to induce a powerful systemic anti tumor immune response. OncoVEXGM-CSF has now been tested in >110 patients in a broad range of solid tumors including melanoma, head & neck cancer, breast cancer and pancreatic cancer. Both the direct cell killing and systemic immune mediated mechanisms of action of OncoVEX have been clearly validated in the clinic; OncoVEX routinely destroys tumors it is directly injected into and has led to overall disease responses in multiple patients in Phase II testing. Tumors resolved through OncoVEX treatment have not been known to recur.

Nanigans

Series A in 2011
Nanigans provides an advertising automation software that powers the in-house performance marketing teams. Offered as Software-as-a-Service, Nanigans software features programmatic media buying, predictive revenue optimization, and real-time business intelligence across today’s most valuable channels. Nanigans is headquartered in Boston, with offices in New York, San Francisco, Seattle, London, Sydney, and Singapore.

Empyr

Series A in 2011
Figg is a card-linked platform company uncovering value for advertisers, publishers, and consumers through trusted data insights. Figg is redefining the way advertisers and consumers connect through everyday purchases. Its card-linked platform features the most diverse portfolio of advertiser-funded offers to enrich savings for consumers. The company enables advertisers to design custom offers aimed at building long-term loyalty for leading social platforms, financial institutions, and mobile apps.

Sitari Pharmaceuticals

Series A in 2013
Sitari Pharmaceuticals is a operator of a biotechnology company intended to develop treatments for multiple disease indications with an initial focus in celiac disease.

Awarepoint Corporation

Series C in 2007
Awarepoint Corporation provides a cloud-based real-time locating system that delivers to track locations. The company offers analytical tools to transform real-time location data into operational intelligence; and managed services that include analysis, configuration, installation, validation, and training. It also provides a Temperature Monitoring System that enables medical facilities to maintain compliance to CDC Vaccines for Children program guidelines and ensure that vaccines are monitored within the recommended temperature range. The company serves clients in healthcare, manufacturing, retail, and other industries. Awarepoint Corporation was formerly known as NeverLost Networks, Inc. The company was founded in 2002 and is based in San Diego, California.

Piper Networks

Venture Round in 2017
Piper Networks powers a new train and worker tracking solution that can finally meet the real-time location awareness requirements of sophisticated transportation systems and their challenging environments. Our suite of proprietary proximity solutions utilize technology like Ultra-Wideband (UWB) and Bluetooth Low Energy (BLE) to offer better performance than other RTLS by providing greater granularity and accuracy to within 10cm,reduced signal latency, added security, and minimal multi path interference. In addition, Piper’s reliable wireless data communication and systems integration experience makes our solution ideal for performing in restrictive locations and congested RF environments like underground subway tunnels.

Vocera Communications

Series F in 2006
Vocera provides mobile communication solutions addressing critical communication challenges facing hospitals today. They help their customers improve patient safety and satisfaction, and increase hospital efficiency and productivity through their Voice Communication solution, Secure Messaging applications and Care Transition solutions. Exclusively endorsed by the American Hospital Association, the Vocera solutions are installed in more than 800 hospitals and healthcare facilities worldwide. The company is headquartered in San Jose, Calif., with offices in Tennessee, Canada and the United Kingdom.

Calporta Therapeutics

Series A in 2015
Calporta is developing selective small molecule agonists of TRPML1 (transient receptor potential cation channel, mucolipin subfamily, member 1) for the treatment of Niemann-Pick C Disease (NPC) and other lysosomal storage diseases. Mutations that cause NPC lead to impaired intracellular lipid trafficking and lead to lysosomal accumulation of cholesterol and biolipds. TRPML1 is an ion channel in the lysosome and a key regulator of lysosomal trafficking processes. Impaired TRPML1 function has been implicated in multiple pathological conditions, including NPC. Agonists of TRPML1 restore calcium efflux and normalize lysosomal trafficking and function. In addition to NPC and other lysosomal storage diseases, agonists of TRPML1 may have broad potential in other diseases such as muscular dystrophy and various taopathies such as Alzheimer's disease. Calporta's approach is based on research from the lab of Haoxing Xu, Ph.D., at the University of Michigan.

Ansata Therapeutics

Series B in 2003
Ansata Therapeutics is a biopharmaceutical company engaged in the development and commercialization of topical drugs for dermatologic indications. It was founded in 2002 and is based in La Jolla, California.
Ankasa Regenerative Therapeutics is a biopharmaceutical company developing strategies to improve tissue healing by exploiting the potential of stem cell reactivation. The company is developing proprietary formulations of a potent WNT stem cell activator with the potential to accelerate tissue healing in a broad range of degenerative conditions affecting bone, cartilage, skin, muscle, vasculature, and the central nervous system. Its proprietary approach has demonstrated superiority for bone reformation over existing standards of care in various preclinical models. Ankasa Regenerative Therapeutics was established in 2014 and is headquartered in La Jolla, California.

NanoNets

Seed Round in 2017
NanoNets is machine learning API for developers which requires 1/10th of data and no machine learning expertise to train a model. Upload the data, wait for a few minutes and get a model you can query over their easy to use cloud API. Often companies do not have enough data to train a machine learning model on their own using state of the art algorithms as well as don't have enough data scientists to work on those problems. NanoNets solves both these problems for companies.

Talla, Inc.

Series A in 2017
Talla is an AI and automation platform that is transforming the way businesses deliver customer support. Talla simultaneously improves customer satisfaction and support rep productivity by automating support workflows and allowing users to self-serve accurate answers to support questions. Unlike other providers, Talla learns and improves over time, provides answers using machine learning, and integrates with all the tools support teams need. Talla was founded in 2015 and is based in Boston, MA.

Orion Labs, Inc.

Series B in 2020
Orion Labs, Inc. provides a voice communication and workflow platform for mobile and heads-up teams that works across a constellation of connected devices, applications, APIs, and AI-powered services. Its solutions include push to talk app, dispatch console, command center, advanced location services, AI workflows, integrations, connected devices, and radio integrations. The company serves hospitality and gaming, field services, transportation, facilities management, manufacturing, energy and mining, construction, retail, and healthcare industries. It sells its products online to customers in the United States and Canada. The company has strategic alliances with ResponderXLabs and the FirstNet Association. Orion Labs, Inc. was formerly known as OnBeep, Inc. and changed its name to Orion Labs in January 2015. The company was founded in 2013 and is headquartered in San Francisco, California.
Syndax Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors. It offers therapies to treat solid tumors and lung, breast, and hematological cancer. The company is developing axatilimab, a monoclonal antibody that blocks the colony-stimulating factor 1 (CSF-1) receptor, in development for chronic Graft versus Host Disease, and entinostat, a class I HDAC inhibitor. Syndax Pharmaceuticals pipeline includes and SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, in development for the treatment of patients with MLLr and NPM1 acute leukemias.

Nanigans

Series B in 2015
Nanigans provides an advertising automation software that powers the in-house performance marketing teams. Offered as Software-as-a-Service, Nanigans software features programmatic media buying, predictive revenue optimization, and real-time business intelligence across today’s most valuable channels. Nanigans is headquartered in Boston, with offices in New York, San Francisco, Seattle, London, Sydney, and Singapore.

AnaptysBio, Inc.

Series B in 2007
AnaptysBio is a privately-held therapeutic antibody product company that uses of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease. The Company's SHM-Platform utilizes the key components of SHM and other techniques to generate antibodies for therapeutic applications through an iterative process of natural evolution and high-throughput selection a process that has been referred to as naturalizing antibodies. This versatile platform can be used both to discover and optimize antibodies directed at specific disease targets and also affinity mature existing antibodies to improve their binding properties. In addition to providing a more powerful approach to antibody discovery and protein optimization, it addresses a growing void in the therapeutic antibody field due to a string of acquisitions and licensing deals that have reduced the availability of many technologies.

Amira Pharmaceuticals

Series A in 2006
Amira Pharmaceuticals is a small molecule pharmaceutical company focused on the discovery and early development of new drugs to treat inflammatory disease. Their discovery team is building on unparalleled insights into bioactive lipid pathways and complex signaling processes controlling many conditions including asthma, chronic obstructive pulmonary disease, cardiovascular and fibrotic diseases.

Awarepoint Corporation

Series D in 2008
Awarepoint Corporation provides a cloud-based real-time locating system that delivers to track locations. The company offers analytical tools to transform real-time location data into operational intelligence; and managed services that include analysis, configuration, installation, validation, and training. It also provides a Temperature Monitoring System that enables medical facilities to maintain compliance to CDC Vaccines for Children program guidelines and ensure that vaccines are monitored within the recommended temperature range. The company serves clients in healthcare, manufacturing, retail, and other industries. Awarepoint Corporation was formerly known as NeverLost Networks, Inc. The company was founded in 2002 and is based in San Diego, California.
EBCC designs and manufactures the highest performance multi-gigabit capacity wireless communication systems based on 71-86 GHz millimeter-wave radio technology. They use highly integrated microwave monolithic integrated circuit (MMIC) technology that enables EBCC to manufacture highest performance wireless systems with a data rate of 1 to 3 Gbps and in the future 10 Gbps over the distances of several miles and availability up to 99.999%. EBCC's "E-Link" system operates at E-band spectrum at 71-76 GHz / 81-86 GHz. The market expects E-Band to solve last mile access bottleneck problems, connect enterprises to fiber networks, and enable backhaul of mobile (3G/4G) and fixed wireless (WiFi, WiMax) networks.

Nanigans

Series A in 2013
Nanigans provides an advertising automation software that powers the in-house performance marketing teams. Offered as Software-as-a-Service, Nanigans software features programmatic media buying, predictive revenue optimization, and real-time business intelligence across today’s most valuable channels. Nanigans is headquartered in Boston, with offices in New York, San Francisco, Seattle, London, Sydney, and Singapore.

AristaMD

Series A in 2016
AristaMD is a healthcare company that features a software platform that helps hospitals and practitioners on improving patient outcomes. It also offers a solution that enables primary care providers to ask questions about patients that they would otherwise refer out and transmit patient clinical notes, history, lab results and images to collaborate on care plans with a panel of on-call, board-certified specialists, all within a matter of hours. The company was founded in 2013 and headquartered in La Jolla, California.

Simulmedia

Series A in 2009
Simulmedia Inc., a technology company, provides a digital advertisement targeting platform for linear television. It provides VAMOS, a data-driven predictive analytics platform for TV. The company also offers TV advertising campaigns. It serves marketers, agencies, TV media owners, and distributors. The company was founded in 2008 and is based in New York, New York with an additional location in San Francisco, California.

Avelas Biosciences

Series B in 2014
Avelas BioSciences, Inc. is a clinical stage biotechnology company that focuses on developing technologies that advance care for cancer surgery and therapeutic intervention. It develops AVB-620, an intravenously administered in vivo fluorescent protease-activatable peptide that detects, marks, and diagnoses cancer. The company was incorporated in 2008 and is based in La Jolla, California.

AlphaSheets

Seed Round in 2015
AlphaSheets seeks to bring the Apple/Slack ethos of intuitive, beautiful computing to currently unintuitive applications. Our main product, AlphaSheets, seeks to eliminate all the problems that plague spreadsheets in the enterprise.

Jnana

Series A in 2017
Jnana Therapeutics Inc. operates a drug discovery platform focused on solute carrier (SLC). The company is focusing on immunometabolism, lysosomal function, and mucosal defense, important disease pathways where SLC transporters provides target for immuno-oncology, inflammatory disorders, and neurological diseases. The company was founded in 2016 and is based in Boston, Massachusetts.

Conjur, Inc.

Venture Round in 2014
For enterprises that are automating their infrastructure, Conjur provides software to identify, authorize, and audit all service and user identities that enables velocity with compliance. With Conjur, customers identify, authorize, and audit every cloud, VM, container, service, job, and user. Conjur addresses critical operational, compliance, and security challenges enterprises face when using a public or hybrid clouds, containers with microservices, and highly automated software delivery processes. By securing infrastructure with Conjur, organizations protect, monitor in real-time, and audit access to critical and sensitive IT systems. In addition to actively enforcing security policy and reducing vulnerability points, Conjur provides detailed activity reports for compliance and security audits. With the cost and frequency of security breaches on the rise, Conjur provides a critical piece of infrastructure to adopt modern IT and maintain compliance. Conjur customers include Discovery Communications, AOL, Cisco (OpenDNS), Puppet Labs, Ability Networks, and Kyruus. Conjur is seed funded by Avalon Partners, Amplify Partners, and Andy Palmer.

Averon US, Inc.

Series A in 2017
Averon US, Inc. develops mobile identity verification technology. It develops Direct Autonomous Authentication (DAA) mobile identity verification standard, which enables smartphone users to seamlessly and securely interact with services and devices like smart locks, without downloading a dedicated application or other software. The company leverages real-time mobile network signaling and the SIM/eSIM (eUICC) chips, requiring no installation, no apps, and no user involvement. It offers authentication solutions for banking, smart vehicles, e-commerce, smart locks, online accounts, and Government. The company was founded in 2015 and is based in San Francisco, California.

Aratana Therapeutics

Series B in 2011
Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.

Happy Cloud

Series A in 2013
The Happy Cloud network lets you play games on demand, much like video on demand for your cable TV--no more waiting for long downloads! Our patent-pending technology pre-installs and pre-packages the game on the network, bypassing the need for installation on the user's end. Our cloud computing-based technology does not use server-side rendering and video streaming, so there is no lag--the game plays the same as it would if you had installed it from a disc. Happy Cloud is true on-demand digital distribution for video games.

Standing Cloud

Venture Round in 2011
Standing Cloud is a leading provider of cloud application management services, providing a seamless application layer for cloud service providers that makes application deployment and management fast, simple and hassle-free for their customers. Its standard application catalog includes 100 open-source and commercial applications. Its Platform-as-as-Service (PaaS) capabilities support multiple programming languages, including Rails, PHP, Java and Python, and a wide range of cloud service providers and orchestration software systems. Founded in 2009, Standing Cloud is based in Boulder, Colorado. Investors include Foundry Group and Avalon Ventures.

Standing Cloud

Series B in 2010
Standing Cloud is a leading provider of cloud application management services, providing a seamless application layer for cloud service providers that makes application deployment and management fast, simple and hassle-free for their customers. Its standard application catalog includes 100 open-source and commercial applications. Its Platform-as-as-Service (PaaS) capabilities support multiple programming languages, including Rails, PHP, Java and Python, and a wide range of cloud service providers and orchestration software systems. Founded in 2009, Standing Cloud is based in Boulder, Colorado. Investors include Foundry Group and Avalon Ventures.

AeroFS

Series B in 2015
AeroFS is an enterprise file sync and share solution. It changes the way creative agencies, consultants, freelancers, and work teams collaborate with their co-workers and clients. The company’s flagship collaboration platform, Amium, makes sharing information and ideas more intuitive and efficient, and dramatically improves and simplifies collaboration with users outside the organization. The service, which stores files in a private cloud-like platform, stores data on the devices designated by the client. AeroFS desktop and server software can run entirely behind a firewall, including authentication. Their vision is to redefine the current view of the ‘cloud’ with better controls, privacy and scalability, whether for administrators, end-users or anyone else.

TwinStrata

Series B in 2011
TwinStrata expands data storage resources via access to cloud storage to help IT organizations reduce costs and improve efficiency

Simulmedia

Series C in 2013
Simulmedia Inc., a technology company, provides a digital advertisement targeting platform for linear television. It provides VAMOS, a data-driven predictive analytics platform for TV. The company also offers TV advertising campaigns. It serves marketers, agencies, TV media owners, and distributors. The company was founded in 2008 and is based in New York, New York with an additional location in San Francisco, California.

Fortis Therapeutics

Series A in 2016
Fortis Therapeutics is an immuno-oncology biotech focused on developing new antibody drug conjugate therapies for late-stage multiple myeloma and late-stage prostate cancer. Fortis Therapeutics was founded based on technology exclusively licensed from UCSF and developed in the laboratory of Bin Liu, Ph.D.

Metra Biosystems

Venture Round in 1992
Metra Biosystems develops and commercializes diagnostic products for the detection and management of metabolic bone and joint diseases and disorders.

Zynga Inc.

Series B in 2008
Zynga develops, markets, and operates social games as live services played on the Internet, social networking sites, and mobile platforms in the United States and internationally. It offers its online social games primarily under the Slots, Words With Friends, Zynga Poker, and FarmVille franchises. The company’s games are accessible on mobile platforms, Facebook, and other social networks. It also provides advertising services to advertising agencies and brokers. Zynga was established in 2007 and is headquartered in San Francisco, California.

Awarepoint Corporation

Series B in 2007
Awarepoint Corporation provides a cloud-based real-time locating system that delivers to track locations. The company offers analytical tools to transform real-time location data into operational intelligence; and managed services that include analysis, configuration, installation, validation, and training. It also provides a Temperature Monitoring System that enables medical facilities to maintain compliance to CDC Vaccines for Children program guidelines and ensure that vaccines are monitored within the recommended temperature range. The company serves clients in healthcare, manufacturing, retail, and other industries. Awarepoint Corporation was formerly known as NeverLost Networks, Inc. The company was founded in 2002 and is based in San Diego, California.
Cambrios Technologies Corp. develops electronic materials for the display industry. The company provides wet-processable transparent conductive films. Its nanostructured materials can be deposited using existing production equipment to achieve enhanced performance of display devices and components. The company was founded in 2002 as Semzyme, Inc. and changed its name to Cambrios Technologies Corp. in August 2004. Cambrios Technologies Corp. is based in Sunnyvale, California.

Kinvey, Inc.

Series B in 2014
Kinvey is the first Backend as a Service that makes it ridiculously easy for developers and enterprises to set up and operate a cloud backend for their mobile, tablet, and web apps. Its service lets app developers spend 100% of their time on their mobile applications. They don't have to worry about connecting to various cloud services or enterprise backend systems, setting up servers for their backend, or maintaining and scaling them. With Kinvey, developers just model their cloud backend needs and we auto-generate all the APIs they would need to access their data from any mobile, web, or computing platform. Developers then grab their APIs and connect to them directly or through native iOS, Android, JavaScript, etc., libraries that we provide. Kinvey is based in Boston, Massachusetts.

Fortis Therapeutics

Series A in 2021
Fortis Therapeutics is an immuno-oncology biotech focused on developing new antibody drug conjugate therapies for late-stage multiple myeloma and late-stage prostate cancer. Fortis Therapeutics was founded based on technology exclusively licensed from UCSF and developed in the laboratory of Bin Liu, Ph.D.

Cloudant

Venture Round in 2011
Cloudant’s distributed database-as-a-service (DBaaS) allows developers of fast-growing web and mobile apps to focus on building and improving their products, instead of worrying about scaling and managing their databases on their own. Cloudant was founded in Cambridge, Massachusetts in 2008 by three MIT physicists who at the time were moving multi-petabyte data sets around from the Large Hadron Collider. Frustrated by the available tools for managing and analyzing Big Data in their research, the founders built a distributed, fault-tolerant, globally scalable data layer on top of Apache CouchDB. The service has grown since then. The team now manages and serves mobile and web app data on behalf of thousands of developers and hundreds of customers to their users around the world.

Aratana Therapeutics

Series A in 2011
Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.

JustSpotted

Seed Round in 2009
Real-time search engine that aggregates and organizes live updates on social media

Quippi

Venture Round in 2014
Quippi Corporation operates as an international shopping card company. It offers gift cards that are sold in the United States and are accepted at retailers in Mexico. The company’s gift card enables its user’s friends or families in a foreign country to spend it at its retail partners. It sells its products through its Website, retail stores, and a network of sales associates. Quippi Corporation was incorporated in 2012 and is based in La Jolla, California. As of October 6, 2015, Quippi Corporation operates as a subsidiary of EMIDA Technologies, Inc.